| Year |
Citation |
Score |
| 2020 |
Nicolaides T, Nazemi KJ, Crawford J, Kilburn L, Minturn J, Gajjar A, Gauvain K, Leary S, Dhall G, Aboian M, Robinson G, Long-Boyle J, Wang H, Molinaro AM, Mueller S, et al. Phase I study of vemurafenib in children with recurrent or progressive BRAF mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002). Oncotarget. 11: 1942-1952. PMID 32523649 DOI: 10.18632/Oncotarget.27600 |
0.345 |
|
| 2020 |
Cluceru J, Nelson SJ, Wen Q, Phillips JJ, Shai A, Molinaro AM, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Chunduru P, Villanueva-Meyer JE, Cha S, Chang SM, Berger MS, et al. Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas. Neuro-Oncology. PMID 32319527 DOI: 10.1093/Neuonc/Noaa094 |
0.305 |
|
| 2020 |
Mathur R, Zhang Y, Grimmer MR, Hong C, Zhang M, Bollam S, Petrecca K, Clarke J, Berger MS, Phillips JJ, Oberheim-Bush NA, Molinaro AM, Chang SM, Costello JF. MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence. Neuro-Oncology. PMID 32166314 DOI: 10.1093/Neuonc/Noaa059 |
0.329 |
|
| 2020 |
Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, et al. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. Jama Oncology. PMID 32027343 DOI: 10.1001/Jamaoncol.2019.6143 |
0.337 |
|
| 2020 |
Oberheim Bush NA, Yu Y, Villanueva-Meyer J, Grimmer M, Hilz S, Solomon D, Choi S, Mazor T, Hong C, Shai A, Phillips JJ, McDermott M, Haas-Kogan DA, Taylor J, Butowski NA, ... ... Molinaro A, et al. Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant diffuse gliomas. Journal of Clinical Oncology. 38: 2506-2506. DOI: 10.1200/Jco.2020.38.15_Suppl.2506 |
0.339 |
|
| 2020 |
Eckel-Passow JE, Drucker KL, Kollmeyer TM, Kosel ML, Decker PA, Molinaro AM, Rice T, Praska CE, Clark LE, Caron AA, Abyzov A, Batzler A, Song JS, Pekmezci M, Hansen HM, et al. Abstract 1193: Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH, FAM20C and GMEB2 Epidemiology. 80: 1193-1193. DOI: 10.1158/1538-7445.Am2020-1193 |
0.314 |
|
| 2019 |
Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, ... ... Molinaro AM, et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature. PMID 31748746 DOI: 10.1038/S41586-019-1775-1 |
0.353 |
|
| 2019 |
Chapman CH, Hara JH, Molinaro AM, Clarke JL, Oberheim Bush NA, Taylor JW, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh DR, Braunstein SE. Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival. Neuro-Oncology Practice. 6: 364-374. PMID 31555451 DOI: 10.1093/Nop/Npz017 |
0.343 |
|
| 2019 |
Breshears JD, Morshed RA, Molinaro AM, McDermott MW, Cheung SW, Theodosopoulos PV. Residual Tumor Volume and Location Predict Progression After Primary Subtotal Resection of Sporadic Vestibular Schwannomas: A Retrospective Volumetric Study. Neurosurgery. PMID 31232426 DOI: 10.1093/Neuros/Nyz200 |
0.317 |
|
| 2019 |
Molinaro AM, Taylor JW, Wiencke JK, Wrensch MR. Genetic and molecular epidemiology of adult diffuse glioma. Nature Reviews. Neurology. PMID 31227792 DOI: 10.1038/S41582-019-0220-2 |
0.321 |
|
| 2019 |
McCurdy S, Molinaro A, Pachter L. Factor analysis for survival time prediction with informative censoring and diverse covariates. Statistics in Medicine. PMID 31162708 DOI: 10.1002/Sim.8151 |
0.31 |
|
| 2019 |
Mueller S, Jain P, Liang WS, Kilburn L, Kline C, Gupta N, Panditharatna E, Magge SN, Zhang B, Zhu Y, Crawford JR, Banerjee A, Nazemi K, Packer RJ, Petritsch CK, ... ... Molinaro A, et al. A pilot precision medicine trial for children with diffuse intrinsic pontine glioma - PNOC003: a report from the Pacific Pediatric Neuro-Oncology Consortium. International Journal of Cancer. PMID 30861105 DOI: 10.1002/Ijc.32258 |
0.338 |
|
| 2019 |
Muskens IS, Hansen HM, Smirnov IV, Molinaro AM, Bondy ML, Schildkraut JM, Wrensch M, Wiemels JL, Claus EB. Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk. Journal of Neuro-Oncology. PMID 30796745 DOI: 10.1007/S11060-019-03119-W |
0.328 |
|
| 2019 |
Morrison MA, Hess CP, Clarke JL, Butowski N, Chang SM, Molinaro AM, Lupo JM. Risk factors of radiotherapy-induced cerebral microbleeds and serial analysis of their size compared with white matter changes: A 7T MRI study in 113 adult patients with brain tumors. Journal of Magnetic Resonance Imaging : Jmri. PMID 30663150 DOI: 10.1002/Jmri.26651 |
0.305 |
|
| 2019 |
Young J, Zhang Y, Molinaro A, Taylor J, Clarke J, Prados M, Chang S, Berger M, Butowski N, Ann Oberheim-Bush N. RTHP-33. A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS ON SURVIVAL BASED ON TREATMENT PARADIGMS FOR PATIENTS WITH ANAPLASTIC OLIGODENDROGLIOMA Neuro-Oncology. 21: vi216-vi217. DOI: 10.1093/Neuonc/Noz175.904 |
0.341 |
|
| 2019 |
Hilz S, Hong C, Jalbert L, Mazor T, Martin M, Kumar A, Shelton S, Wong K, Hayes J, Yu Y, Zhang M, Luks T, Olson M, Lafontaine M, Shai A, ... ... Molinaro A, et al. GENE-47. A 3D ATLAS TO EVALUATE THE SPATIAL PATTERNING OF GENETIC ALTERATIONS AND TUMOR CELL STATES IN GLIOMA Neuro-Oncology. 21: vi107-vi108. DOI: 10.1093/Neuonc/Noz175.449 |
0.322 |
|
| 2019 |
Mathur R, Zhang Y, Grimmer M, Hong C, Berger M, Molinaro A, Ann Oberheim-Bush N, Chang S, Costello J. GENE-35. MGMT PROMOTER METHYLATION IN NEWLY DIAGNOSED LGG AS A POTENTIAL BIOMARKER FOR TMZ-ASSOCIATED HYPERMUTATION AT RECURRENCE Neuro-Oncology. 21: vi105-vi105. DOI: 10.1093/Neuonc/Noz175.437 |
0.334 |
|
| 2019 |
Taylor J, Molinaro A, Rodriguez Almaraz E, Downey C, Phillips J, Ann Oberheim-Bush N, Butowski N, Chang S, Berger M, Prados M, Haas-Kogan D, Clarke J. ACTR-42. PI3K/mTOR PATHWAY ACTIVATION SELECTED PHASE II STUDY OF EVEROLIMUS (RAD001) WITH AND WITHOUT TEMOZOLOMIDE IN THE TREATMENT OF ADULT PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMA [NCT NCT02023905] Neuro-Oncology. 21: vi22-vi23. DOI: 10.1093/Neuonc/Noz175.084 |
0.348 |
|
| 2018 |
Luks TL, McKnight TR, Jalbert LE, Williams A, Neill E, Lobo KA, Persson AI, Perry A, Phillips JJ, Molinaro AM, Chang SM, Nelson SJ. Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas. Translational Oncology. 11: 941-949. PMID 29883968 DOI: 10.1016/J.Tranon.2018.05.005 |
0.326 |
|
| 2018 |
Chandra A, Rick JW, Dalle Ore C, Lau D, Nguyen AT, Carrera D, Bonte A, Molinaro AM, Theodosopoulos PV, McDermott MW, Berger MS, Aghi MK. Disparities in health care determine prognosis in newly diagnosed glioblastoma. Neurosurgical Focus. 44: E16. PMID 29852776 DOI: 10.3171/2018.3.Focus1852 |
0.333 |
|
| 2017 |
Taylor JW, Molinaro AM, Butowski N, Prados M. Clinical trial endpoints for patients with gliomas. Neuro-Oncology Practice. 4: 201-208. PMID 31385993 DOI: 10.1093/Nop/Npw034 |
0.305 |
|
| 2017 |
Byron SA, Tran NL, Halperin RF, Phillips JJ, Kuhn JG, de Groot JF, Colman H, Ligon KL, Wen PY, Cloughesy TF, Mellinghoff IK, Butowski N, Taylor J, Clarke JL, Chang SM, ... ... Molinaro AM, et al. Prospective feasibility trial for genomics-informed treatment in recurrent and progressive glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29074604 DOI: 10.1158/1078-0432.Ccr-17-0963 |
0.302 |
|
| 2017 |
Jacobs DI, Liu Y, Gabrusiewicz K, Tsavachidis S, Armstrong GN, Zhou R, Wei J, Ivan C, Calin G, Molinaro AM, Rice T, Bracci PM, Hansen HM, Wiencke JK, Wrensch MR, et al. Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients. Journal of Neuro-Oncology. PMID 28965162 DOI: 10.1007/S11060-017-2622-6 |
0.321 |
|
| 2017 |
Autry A, Phillips JJ, Maleschlijski S, Roy R, Molinaro AM, Chang SM, Cha S, Lupo JM, Nelson SJ. Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor. Translational Oncology. 10: 895-903. PMID 28942218 DOI: 10.1016/J.Tranon.2017.08.009 |
0.325 |
|
| 2017 |
Anwar M, Molinaro AM, Morin O, Chang SM, Haas-Kogan DA, Nelson SJ, Lupo JM. Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI. Radiation Research. PMID 28723274 DOI: 10.1667/Rr14662.1 |
0.332 |
|
| 2017 |
Jalbert LE, Elkhaled A, Phillips JJ, Neill E, Williams A, Crane JC, Olson MP, Molinaro AM, Berger MS, Kurhanewicz J, Ronen SM, Chang SM, Nelson SJ. Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma. Scientific Reports. 7: 44792. PMID 28327577 DOI: 10.1038/Srep44792 |
0.352 |
|
| 2017 |
Pekmezci M, Rice T, Molinaro AM, Walsh KM, Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G, Perry A, Giannini C, Tihan T, Berger MS, Wiemels JL, et al. Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT. Acta Neuropathologica. PMID 28255664 DOI: 10.1007/S00401-017-1690-1 |
0.323 |
|
| 2017 |
Wiencke JK, Koestler DC, Salas LA, Wiemels JL, Roy RP, Hansen HM, Rice T, McCoy LS, Bracci PM, Molinaro AM, Kelsey KT, Wrensch MR, Christensen BC. Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival. Clinical Epigenetics. 9: 10. PMID 28184256 DOI: 10.1186/S13148-017-0316-8 |
0.362 |
|
| 2017 |
Neill E, Luks T, Dayal M, Phillips JJ, Perry A, Jalbert LE, Cha S, Molinaro A, Chang SM, Nelson SJ. Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma. Journal of Neuro-Oncology. PMID 28124178 DOI: 10.1007/S11060-016-2355-Y |
0.34 |
|
| 2017 |
Nicolaides T, Nazemi K, Crawford J, Kilburn L, Minturn J, Gajjar A, Gauvain K, Leary S, Dhall G, Aboian M, Robinson G, Molinaro A, Mueller S, Prados M. PDCT-19. A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAFV600E, IN CHILDREN WITH RECURRENT/REFRACTORY BRAFV600E MUTANT BRAIN TUMORS: PNOC-002 Neuro-Oncology. 19: vi188-vi188. DOI: 10.1093/Neuonc/Nox168.761 |
0.309 |
|
| 2017 |
Taylor JW, Molinaro AM, Phillips JJ, James CD, Butowski NA, Clarke JL, Oberheim Bush N, Chang SM, Berger MS, Prados M. P09.59 Phase 2 trial of palbociclib in adult patients with recurrent Rb positive glioblastoma Neuro-Oncology. 19: iii83-iii83. DOI: 10.1093/Neuonc/Nox036.314 |
0.332 |
|
| 2016 |
Nelson SJ, Kadambi AK, Park I, Li Y, Crane J, Olson M, Molinaro A, Roy R, Butowski N, Cha S, Chang S. Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen. Neuro-Oncology. PMID 27576874 DOI: 10.1093/Neuonc/Now159 |
0.334 |
|
| 2016 |
Wahl M, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan DA, Costello JF, Dayal M, Butowski N, Clarke JL, Prados M, Nelson S, Berger MS, Chang SM. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide. Neuro-Oncology. PMID 27571885 DOI: 10.1093/Neuonc/Now176 |
0.331 |
|
| 2016 |
Nelson SJ, Li Y, Lupo JM, Olson M, Crane JC, Molinaro A, Roy R, Clarke J, Butowski N, Prados M, Cha S, Chang SM. Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab. Journal of Neuro-Oncology. PMID 27535746 DOI: 10.1007/S11060-016-2229-3 |
0.357 |
|
| 2016 |
Molinaro AM, Sison JD, Ljung BM, Tlsty TD, Kerlikowske K. Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy. Breast Cancer Research and Treatment. PMID 27146587 DOI: 10.1007/S10549-016-3814-Z |
0.311 |
|
| 2016 |
Steingrimsson JA, Diao L, Molinaro AM, Strawderman RL. Doubly robust survival trees. Statistics in Medicine. PMID 27037609 DOI: 10.1002/Sim.6949 |
0.333 |
|
| 2016 |
Rice T, Lachance DH, Molinaro AM, Eckel-Passow JE, Walsh KM, Barnholtz-Sloan J, Ostrom QT, Francis SS, Wiemels J, Jenkins RB, Wiencke JK, Wrensch MR. Understanding inherited genetic risk of adult glioma - a review. Neuro-Oncology Practice. 3: 10-16. PMID 26941959 DOI: 10.1093/Nop/Npv026 |
0.303 |
|
| 2016 |
Jalbert LE, Neill E, Phillips JJ, Lupo JM, Olson MP, Molinaro AM, Berger MS, Chang SM, Nelson SJ. Magnetic resonance analysis of malignant transformation in recurrent glioma. Neuro-Oncology. PMID 26911151 DOI: 10.1093/Neuonc/Now008 |
0.323 |
|
| 2016 |
Prados M, Kuhn JG, Colman H, Cloughesy TF, Chang SM, Butowski NA, De Groot JF, Wen PY, Ligon KL, Mellinghoff IK, Chi AS, Phillips JJ, Molinaro AM, Halperin R, Tran N, et al. Precision medicine in recurrent glioblastoma: A feasibility trial conducted by the Ivy Foundation Early Phase Clinical Trials Consortium. Journal of Clinical Oncology. 34: 2031-2031. DOI: 10.1200/Jco.2016.34.15_Suppl.2031 |
0.344 |
|
| 2016 |
Wahl MT, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan D, Costello JF, Dayal M, Butowski NA, Clarke JL, Prados M, Berger MS, Nelson SJ, Chang SM. Adjuvant temozolomide for low grade gliomas: Molecular and radiographic correlates of treatment response in a phase II clinical trial. Journal of Clinical Oncology. 34: 2002-2002. DOI: 10.1200/Jco.2016.34.15_Suppl.2002 |
0.348 |
|
| 2015 |
Wen Q, Jalilian L, Lupo JM, Li Y, Roy R, Molinaro AM, Chang SM, Prados M, Butowski N, Clarke J, Nelson SJ. Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials. Translational Oncology. 8: 446-55. PMID 26692525 DOI: 10.1016/J.Tranon.2015.10.001 |
0.323 |
|
| 2015 |
Walsh KM, Codd V, Rice T, Nelson CP, Smirnov IV, McCoy LS, Hansen HM, Elhauge E, Ojha J, Francis SS, Madsen NR, Bracci PM, Pico AR, Molinaro AM, Tihan T, et al. Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk. Oncotarget. PMID 26646793 DOI: 10.18632/Oncotarget.6468 |
0.325 |
|
| 2015 |
Lau D, Hervey-Jumper SL, Chang S, Molinaro AM, McDermott MW, Phillips JJ, Berger MS. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas. Journal of Neurosurgery. 1-10. PMID 26544781 DOI: 10.3171/2015.5.Jns1577 |
0.328 |
|
| 2015 |
Mazor T, Pankov A, Johnson BE, Hong C, Hamilton EG, Bell RJ, Smirnov IV, Reis GF, Phillips JJ, Barnes MJ, Idbaih A, Alentorn A, Kloezeman JJ, Lamfers ML, Bollen AW, ... ... Molinaro AM, et al. DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors. Cancer Cell. 28: 307-17. PMID 26373278 DOI: 10.1016/J.Ccell.2015.07.012 |
0.305 |
|
| 2015 |
Hervey-Jumper SL, Li J, Osorio JA, Lau D, Molinaro AM, Benet A, Berger MS. Surgical assessment of the insula. Part 2: validation of the Berger-Sanai zone classification system for predicting extent of glioma resection. Journal of Neurosurgery. 1-7. PMID 26339856 DOI: 10.3171/2015.4.Jns1521 |
0.327 |
|
| 2015 |
Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. The New England Journal of Medicine. 372: 2499-508. PMID 26061753 DOI: 10.1056/Nejmoa1407279 |
0.305 |
|
| 2015 |
Walsh KM, Wiencke JK, Lachance DH, Wiemels JL, Molinaro AM, Eckel-Passow JE, Jenkins RB, Wrensch MR. Telomere maintenance and the etiology of adult glioma. Neuro-Oncology. 17: 1445-52. PMID 26014050 DOI: 10.1093/Neuonc/Nov082 |
0.317 |
|
| 2015 |
Sneed PK, Mendez J, Vemer-van den Hoek JG, Seymour ZA, Ma L, Molinaro AM, Fogh SE, Nakamura JL, McDermott MW. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. Journal of Neurosurgery. 123: 373-86. PMID 25978710 DOI: 10.3171/2014.10.Jns141610 |
0.314 |
|
| 2015 |
Reis GF, Pekmezci M, Hansen HM, Rice T, Marshall RE, Molinaro AM, Phillips JJ, Vogel H, Wiencke JK, Wrensch MR, Walsh KM, Perry A. CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas. Journal of Neuropathology and Experimental Neurology. 74: 442-52. PMID 25853694 DOI: 10.1097/Nen.0000000000000188 |
0.316 |
|
| 2015 |
van Thuijl HF, Mazor T, Johnson BE, Fouse SD, Aihara K, Hong C, Malmström A, Hallbeck M, Heimans JJ, Kloezeman JJ, Stenmark-Askmalm M, Lamfers ML, Saito N, Aburatani H, Mukasa A, ... ... Molinaro AM, et al. Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment. Acta Neuropathologica. 129: 597-607. PMID 25724300 DOI: 10.1007/S00401-015-1403-6 |
0.331 |
|
| 2015 |
Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, Bondy ML, Berger M, Jenkins R, Wrensch M. Survival and low-grade glioma: the emergence of genetic information. Neurosurgical Focus. 38: E6. PMID 25552286 DOI: 10.3171/2014.10.Focus12367 |
0.368 |
|
| 2015 |
Wen Q, Jalilian L, Lupo JM, Molinaro AM, Chang SM, Clarke J, Prados M, Nelson SJ. Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab. Journal of Neuro-Oncology. 121: 331-9. PMID 25351579 DOI: 10.1007/S11060-014-1636-6 |
0.377 |
|
| 2015 |
Luks T, McKnight TR, Williams A, Lobo K, Persson A, Phillips J, Molinaro A, Chang S, Nelson S. NIMG-48MR DIFFUSION PROFILES OF NON-ENHANCING LOWER-GRADE GLIOMAS Neuro-Oncology. 17: v164.4-v165. DOI: 10.1093/Neuonc/Nov225.48 |
0.341 |
|
| 2015 |
Walsh K, Pekmezci M, Decker P, Hansen H, Sicotte H, Rice T, Kollmeyer T, McCoy L, Sarkar G, Perry A, Giannini C, Tihan T, Berger M, Molinaro A, Wiemels J, et al. EPID-31ATRX AND TERT ASSAYS PROVIDE NON-REDUNDANT INFORMATION IN ADULT GLIOMA PATIENTS: INCORPORATING TELOMERE MARKERS INTO NEUROPATHOLOGY PRACTICE Neuro-Oncology. 17: v85.1-v85. DOI: 10.1093/Neuonc/Nov213.31 |
0.368 |
|
| 2015 |
Rice T, Lachance D, Molinaro A, Eckel-Passow J, Walsh K, Barnholtz-Sloan J, Ostrum Q, Francis S, Wiemels J, Jenkins R, Wiencke J, Wrensch M. EPID-23UNDERSTANDING INHERITED GENETIC RISK OF ADULT GLIOMA - A REVIEW Neuro-Oncology. 17: v83.1-v83. DOI: 10.1093/Neuonc/Nov213.23 |
0.303 |
|
| 2015 |
Wahl M, Aicardi J, Molinaro A, Haas-Kogan D, Butowski N, Clarke J, Prados M, Phillips J, Berger M, Chang S. ATCT-32A PHASE II STUDY OF TEMOZOLOMIDE IN THE TREATMENT OF ADULT PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMA Neuro-Oncology. 17: v8.4-v9. DOI: 10.1093/Neuonc/Nov206.32 |
0.36 |
|
| 2015 |
Lau D, Hervey-Jumper S, Chang S, Molinaro A, McDermott M, Phillips J, Berger M. ATCT-21A PROSPECTIVE PHASE II CLINICAL TRIAL OF 5-AMINOLEVULINIC ACID TO CORRELATE INTRAOPERATIVE FLUORESCENCE INTENSITY WITH HISTOLOGIC CELLULARITY Neuro-Oncology. 17: v6.1-v6. DOI: 10.1093/Neuonc/Nov206.21 |
0.318 |
|
| 2014 |
Schoenfeld A, Haas-Kogan DA, Molinaro A, Banerjee A, Nicolaides T, Tihan T, Bollen AW, Gupta N, Mueller S. Pure germinomas of the central nervous system: treatment strategies and outcomes. Journal of Neuro-Oncology. 120: 643-9. PMID 25189788 DOI: 10.1007/S11060-014-1599-7 |
0.314 |
|
| 2014 |
Sun MZ, Ivan ME, Oh MC, Delance AR, Clark AJ, Safaee M, Oh T, Kaur G, Molinaro A, Gupta N, Parsa AT. Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma. Journal of Neuro-Oncology. 120: 353-60. PMID 25106865 DOI: 10.1007/S11060-014-1559-2 |
0.315 |
|
| 2014 |
Elkhaled A, Jalbert L, Constantin A, Yoshihara HA, Phillips JJ, Molinaro AM, Chang SM, Nelson SJ. Characterization of metabolites in infiltrating gliomas using ex vivo ¹H high-resolution magic angle spinning spectroscopy. Nmr in Biomedicine. 27: 578-93. PMID 24596146 DOI: 10.1002/Nbm.3097 |
0.352 |
|
| 2014 |
Sun MZ, Ivan ME, Clark AJ, Oh MC, Delance AR, Oh T, Safaee M, Kaur G, Bloch O, Molinaro A, Gupta N, Parsa AT. Gross total resection improves overall survival in children with choroid plexus carcinoma. Journal of Neuro-Oncology. 116: 179-85. PMID 24166581 DOI: 10.1007/S11060-013-1281-5 |
0.351 |
|
| 2014 |
Jalbert L, Phillips J, Molinaro A, Chang S, Nelson S. NI-40 * MR IMAGING AND SPECTROSCOPY PROVIDES INSIGHT INTO MALIGNANT TRANSFORMATION AND IDH-MUTATION STATUS IN DIFFUSE LOW-GRADE GLIOMA Neuro-Oncology. 16: v146-v147. DOI: 10.1093/Neuonc/Nou264.38 |
0.344 |
|
| 2014 |
Hervey-Jumper S, Li J, Lau D, Molinaro A, Perry D, Meng L, Berger M. NC-06 * AWAKE CRANIOTOMY TO MAXIMIZE GLIOMA RESECTION: METHODS AND TECHNICAL NUANCES Neuro-Oncology. 16: v135-v135. DOI: 10.1093/Neuonc/Nou263.6 |
0.333 |
|
| 2014 |
Eckel-Passow J, Lachance D, Walsh K, Decker P, Sicotte H, Pekmezci M, Molinaro A, Rice T, Kosel M, Smirnov I, Sarkar G, Caron A, Kollmeyer T, Giannini C, Huse J, et al. GE-09 * TERT PROMOTER MUTATION, IDH MUTATION AND 1p/19q CODELETION DEFINE FIVE GLIOMA MOLECULAR GROUPS WITH SPECIFIC CLINICAL CHARACTERISTICS AND GERMLINE VARIANT ASSOCIATIONS Neuro-Oncology. 16: v98-v98. DOI: 10.1093/Neuonc/Nou256.9 |
0.318 |
|
| 2014 |
Mazor T, Pankov A, Johnson BE, Hong C, Bell RJA, Smirnov IV, Reis GF, Phillips JJ, Barnes M, Bollen AW, Taylor BS, Molinaro AM, Olshen AB, Song JS, Berger MS, et al. EG-07 * CELL CYCLE SIGNATURE AND TUMOR PHYLOGENY ARE ENCODED IN THE EVOLUTIONARY DYNAMICS OF DNA METHYLATION IN GLIOMA Neuro-Oncology. 16: v76-v76. DOI: 10.1093/Neuonc/Nou254.7 |
0.341 |
|
| 2014 |
Costello JF, Mazor T, Pankov A, Johnson BE, Hong C, Bell RJA, Smirnov IV, Reis GF, Phillips JJ, Barnes M, Bollen AW, Taylor BS, Molinaro AM, Olshen AB, Song JS, et al. CLONAL EVOLUTION OF GLIOMAS IS ENCODED IN THE EVOLUTIONARY DYNAMICS OF DNA METHYLATION Neuro-Oncology. 16: iii51-iii52. DOI: 10.1093/Neuonc/Nou209.38 |
0.336 |
|
| 2014 |
Clarke JL, Chang S, Phillips J, Molinaro A, Berger M, Nelson S, Haas-Kogan D. EVEROLIMUS (RAD001) AND THE MTOR PATHWAY IN LOW-GRADE GLIOMAS Neuro-Oncology. 16: iii48-iii48. DOI: 10.1093/Neuonc/Nou209.24 |
0.379 |
|
| 2014 |
Wrensch M, Walsh KM, Smirnov IV, Rice T, Hansen HM, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, Perry A, Marshall R, Pekmezci M, Zheng S, Wiemels JL, Tihan T, et al. SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) ASSOCIATED WITH GLIOMA SURVIVAL Neuro-Oncology. 16: iii2-iii2. DOI: 10.1093/Neuonc/Nou206.7 |
0.339 |
|
| 2014 |
Molinaro AM, Olshen A, Strawderman R. TREE DERIVED SURVIVAL RISK GROUPS IN DIFFERENTIATING RISK FOR GLIOMA PATIENTS Neuro-Oncology. 16: iii2-iii2. DOI: 10.1093/Neuonc/Nou206.5 |
0.339 |
|
| 2014 |
Nelson SJ, Elkhaled A, Jalbert L, Wen Q, Phillips JJ, Molinaro A, Berger M, Chang SM. EX VIVO METABOLIC SIGNATURES OF GLIOMAS BASED UPON TUMOR GRADE, IMAGING CHARACTERISTICS AND TREATMENT HISTORY Neuro-Oncology. 16: iii12-iii13. DOI: 10.1093/Neuonc/Nou206.44 |
0.343 |
|
| 2014 |
Chang SM, Elkhaled A, Jalbert L, Phillips JJ, Cha S, Molinaro A, Nelson SJ. IMAGING BIOMARKERS OF MALIGNANT PROGRESSION OF DIFFUSE LOW-GRADE GLOMA (LGG) Neuro-Oncology. 16: iii1-iii22. DOI: 10.1093/Neuonc/Nou206.43 |
0.369 |
|
| 2014 |
Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, Kollmeyer T, Kosel ML, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, Pekmezci M, Zheng S, Wiemels JL, et al. Telomere Length Variants Are Associated With High-Grade Glioma Risk: Identification Of A Novel Glioma Risk Locus By Genome-Wide Association Study Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou206.4 |
0.317 |
|
| 2014 |
Han SJ, Rutledge WC, Molinaro AM, Chang S, Clarke JL, Prados MD, Berger MS, Butowski NA. P17.38 * THE EFFECT OF TIMING OF RADIOTHERAPY (RT) IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) RECEIVING TEMOZOLOMIDE (TMZ): AN ANALYSIS BASED ON THE UCSF EXPERIENCE Neuro-Oncology. 16: ii96-ii96. DOI: 10.1093/Neuonc/Nou174.367 |
0.343 |
|
| 2013 |
Walsh KM, Rice T, Decker PA, Kosel ML, Kollmeyer T, Hansen HM, Zheng S, McCoy LS, Bracci PM, Anderson E, Hsuang G, Wiemels JL, Pico AR, Smirnov I, Molinaro AM, et al. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro-Oncology. 15: 1041-7. PMID 23733245 DOI: 10.1093/Neuonc/Not051 |
0.312 |
|
| 2013 |
Safaee M, Oh MC, Sughrue ME, Delance AR, Bloch O, Sun M, Kaur G, Molinaro AM, Parsa AT. The relative patient benefit of gross total resection in adult choroid plexus papillomas. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 20: 808-12. PMID 23623658 DOI: 10.1016/J.Jocn.2012.08.003 |
0.348 |
|
| 2013 |
Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, ... ... Molinaro AM, et al. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Brain Pathology (Zurich, Switzerland). 23: 565-73. PMID 23438035 DOI: 10.1111/Bpa.12043 |
0.329 |
|
| 2013 |
Lupo JM, Essock-Burns E, Molinaro AM, Cha S, Chang SM, Butowski N, Nelson SJ. Using susceptibility-weighted imaging to determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in patients with glioblastoma multiforme. Neuro-Oncology. 15: 480-9. PMID 23393208 DOI: 10.1093/Neuonc/Nos325 |
0.327 |
|
| 2013 |
Essock-Burns E, Phillips JJ, Molinaro AM, Lupo JM, Cha S, Chang SM, Nelson SJ. Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM. Journal of Magnetic Resonance Imaging : Jmri. 38: 388-400. PMID 23281184 DOI: 10.1002/Jmri.23982 |
0.317 |
|
| 2013 |
Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG, Schultz CJ, Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M, Molinaro A, Mischel P, Dicker AP, Bredel M, et al. RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. International Journal of Radiation Oncology, Biology, Physics. 85: 1206-11. PMID 23182702 DOI: 10.1016/J.Ijrobp.2012.10.008 |
0.313 |
|
| 2013 |
Haas-Kogan D, Phillips JJ, Molinaro A, Wahl M, Mueller S, Weiss WA, Lupo JM, Berger MS, Prados MD, Butowski N, Clarke J, Perry A, Nelson SJ, Chang S. Abstract 3520: Imaging parameters and molecular correlates as predictive markers of treatment response to mTOR inhibition in adults with recurrent low-grade gliomas. Cancer Research. 73: 3520-3520. DOI: 10.1158/1538-7445.Am2013-3520 |
0.36 |
|
| 2012 |
Engler JR, Robinson AE, Smirnov I, Hodgson JG, Berger MS, Gupta N, James CD, Molinaro A, Phillips JJ. Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas. Plos One. 7: e43339. PMID 22937035 DOI: 10.1371/Journal.Pone.0043339 |
0.313 |
|
| 2012 |
Lostritto K, Strawderman RL, Molinaro AM. A partitioning deletion/substitution/addition algorithm for creating survival risk groups. Biometrics. 68: 1146-56. PMID 22519965 DOI: 10.1111/J.1541-0420.2012.01756.X |
0.333 |
|
| 2012 |
Potts MB, Smith JS, Molinaro AM, Berger MS. Natural history and surgical management of incidentally discovered low-grade gliomas. Journal of Neurosurgery. 116: 365-72. PMID 21999317 DOI: 10.3171/2011.9.Jns111068 |
0.309 |
|
| 2012 |
Clarke JL, Molinaro AM, Butowski NA, Chang SM, Phillips JJ, Costa BM, Costello JF, Rabbitt JE, Kivett VA, DeSilva AA, Prados M. A single-institution phase II trial of radiation (RT), temozolomide (TMZ), erlotinib, and bevacizumab for initial treatment of glioblastoma (GBM). Journal of Clinical Oncology. 30: 2026-2026. DOI: 10.1200/Jco.2012.30.15_Suppl.2026 |
0.307 |
|
| 2011 |
Tolles J, Bai Y, Baquero M, Harris LN, Rimm DL, Molinaro AM. Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma. Breast Cancer Research : Bcr. 13: R51. PMID 21592345 DOI: 10.1186/Bcr2882 |
0.307 |
|
| 2010 |
Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, Sanchez H, Jimenez C, Stewart K, Chew K, Ljung BM, Tlsty TD. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. Journal of the National Cancer Institute. 102: 627-37. PMID 20427430 DOI: 10.1093/Jnci/Djq101 |
0.309 |
|
| 2010 |
Molinaro AM, Lostritto K, van der Laan M. partDSA: deletion/substitution/addition algorithm for partitioning the covariate space in prediction. Bioinformatics (Oxford, England). 26: 1357-63. PMID 20375111 DOI: 10.1093/Bioinformatics/Btq142 |
0.5 |
|
| 2010 |
Boffa DJ, Guo X, Molinaro A, Finan B, Detterbeck F, Rimm DL. Abstract 2234: Circulating tumor cells are rare in patients with curable oligometastatic cancer Cancer Research. 70: 2234-2234. DOI: 10.1158/1538-7445.Am10-2234 |
0.314 |
|
| 2009 |
Halaban R, Krauthammer M, Pelizzola M, Cheng E, Kovacs D, Sznol M, Ariyan S, Narayan D, Bacchiocchi A, Molinaro A, Kluger Y, Deng M, Tran N, Zhang W, Picardo M, et al. Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. Plos One. 4: e4563. PMID 19234609 DOI: 10.1371/Journal.Pone.0004563 |
0.322 |
|
| 2008 |
Petersen ML, Molinaro AM, Sinisi SE, van der Laan MJ. Cross-Validated Bagged Learning. Journal of Multivariate Analysis. 25: 260-266. PMID 19255599 DOI: 10.1016/J.Jmva.2007.07.004 |
0.717 |
|
| 2006 |
Moore LE, Fung ET, McGuire M, Rabkin CC, Molinaro A, Wang Z, Zhang F, Wang J, Yip C, Meng XY, Pfeiffer RM. Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1641-6. PMID 16985025 DOI: 10.1158/1055-9965.Epi-05-0980 |
0.304 |
|
| 2006 |
Hothorn T, Bühlmann P, Dudoit S, Molinaro A, van der Laan MJ. Survival ensembles. Biostatistics (Oxford, England). 7: 355-73. PMID 16344280 DOI: 10.1093/biostatistics/kxj011 |
0.479 |
|
| 2004 |
Molinaro AM, Dudoit S, Van Der Laan MJ. Tree-based multivariate regression and density estimation with right-censored data Journal of Multivariate Analysis. 90: 154-177. DOI: 10.1016/J.Jmva.2004.02.003 |
0.326 |
|
| 2003 |
Dudoit S, van der Laan MJ, Keleş S, Molinaro AM, Sinisi SE, Teng SL. Loss-based estimation with cross-validation Acm Sigkdd Explorations Newsletter. 5: 56-68. DOI: 10.1145/980972.980981 |
0.731 |
|
| Show low-probability matches. |